1
|
Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy. Vaccines (Basel) 2022; 10:vaccines10070998. [PMID: 35891162 PMCID: PMC9322313 DOI: 10.3390/vaccines10070998] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2022] [Revised: 06/10/2022] [Accepted: 06/20/2022] [Indexed: 12/24/2022] Open
Abstract
Evidence on the human papillomavirus (HPV) vaccine shows that it is effective in reducing the burden of HPV-related diseases. For more than 15 years the HPV vaccine has been offered free of charge in Italy to girls from the age of 12. Over time, the free offer of the HPV vaccine has also been extended to boys and to young adults at risk of developing HPV lesions. Despite the HPV vaccine’s effectiveness and availability, vaccination coverage is low in Italy, with a reported value of 46.5% in 2020. Furthermore, in the southern administrative regions, vaccination coverage is even lower than national values, with 25.9% coverage in Sicily. A cross-sectional study was conducted among university and high school students in the Palermo area (Sicily, Italy) in order to identify the determinants of HPV vaccination adherence by using a questionnaire that investigated factors of HPV vaccine practice. The study explored the behavioral attitude by using the Health Belief Model (HBM), and also used the SILS test and the METER test to investigate the level of health literacy (HL). Overall, 3,073 students were enrolled, and less than a third reported they had completed the vaccination schedule (n = 925, 30.1%). Multivariable analysis showed that the factors directly associated with the adherence to HPV vaccination were female sex (OR = 4.43, p < 0.001), high HBM total score (OR = 4.23, p < 0.001), good HL level (OR = 1.26, p = 0.047), parents (OR = 1.78, p = 0.004), general practitioner (OR = 1.88, p = 0.001), and educational material provided by public vaccination services (OR = 1.97, p = 0.001) as HPV vaccine information sources. Further health-promotion programs focused on improving HL and perception of the HPV vaccine’s benefits should be implemented in order to achieve the desirable 95% vaccination coverage.
Collapse
|
2
|
Could a Behavioral Model Explain Adherence to Second-Level Colonoscopy for Colon Cancer Screening? Results of a Cross-Sectional Study of the Palermo Province Population. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19052782. [PMID: 35270473 PMCID: PMC8910366 DOI: 10.3390/ijerph19052782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Revised: 02/24/2022] [Accepted: 02/25/2022] [Indexed: 12/04/2022]
Abstract
According to Italian Essential Levels of Assistance (ELA), a colonoscopy is strongly recommended after a positive fecal occult blood test (FOBT) due to its effectiveness in early colorectal cancer detection. Despite the evidence, the Palermo province population (Italy), after a positive FOBT, have a lower colonoscopy adherence compared to Italian standards. This cross-sectional study analyzed patients’ perceptions of colonoscopy procedures to understand the reasons for non-adherence. Patients with a positive FOBT who did not undergo a colonoscopy within the national organized screening program were administered a telephone interview based on the Health Belief Model (HBM) questionnaire. The number of non-compliant patients with a colonoscopy after a positive FOBT were 182, of which 45 (25.7%) patients had undergone a colonoscopy in another healthcare setting. Among the HBM items, in a multivariate analysis only perceived benefits were significantly associated with colonoscopy adherence (aOR = 6.7, p = 0.03). Health promotion interventions should focus on the importance of the benefits of colorectal screening adherence to prevent colorectal cancer, implementing health communication by healthcare workers that have closer contacts with people, as general practitioners.
Collapse
|
3
|
Dembiński Ł, Vieira Martins M, Huss G, Grossman Z, Barak S, Magendie C, Del Torso S, Dornbusch HJ, Mazur A, Albrecht K, Hadjipanayis A. SARS-CoV-2 Vaccination in Children and Adolescents-A Joint Statement of the European Academy of Paediatrics and the European Confederation for Primary Care Paediatricians. Front Pediatr 2021; 9:721257. [PMID: 34497784 PMCID: PMC8419337 DOI: 10.3389/fped.2021.721257] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/06/2021] [Accepted: 07/31/2021] [Indexed: 12/18/2022] Open
Abstract
Stopping the COVID-19 pandemic and its socio-economic consequences is only possible with a multifaceted strategy, including mass vaccination. Studies have been conducted mainly in adults, and data on the pediatric population is relatively limited. However, it appears that vaccination in children and adolescents is highly effective and safe. Despite the apparent benefits of vaccinating this age group, there are some medical and ethical concerns. Based on the above considerations, the European Academy of Paediatrics (EAP) and the European Confederation of Primary Care Pediatricians (ECPCP) assessed the current situation and presented recommendations for international and national authorities, pediatricians, and pediatric societies regarding vaccination against SARS-CoV-2 in children and adolescents.
Collapse
Affiliation(s)
- Łukasz Dembiński
- The European Academy of Paediatrics, Brussels, Belgium.,Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Warsaw, Poland
| | - Miguel Vieira Martins
- Young European Academy of Paediatrics, Brussels, Belgium.,Pediatrics Department, Cova da Beira University Hospital Centre, Covilha, Portugal
| | - Gottfried Huss
- The European Confederation of Primary Care Paediatricians, Lyon, France.,Kinder-Permanence Spital Zollikerberg, Zollikerberg, Switzerland
| | - Zachi Grossman
- The European Academy of Paediatrics, Brussels, Belgium.,Adelson School of Medicine, Ariel University, Ariel, Israel.,Maccabi Health Services, Tel Aviv, Israel
| | - Shimon Barak
- The European Confederation of Primary Care Paediatricians, Lyon, France.,Tel Aviv Sourasky Medical Center, Dana-Dwek Children's Hospital, Tel Aviv, Israel
| | - Christine Magendie
- The European Confederation of Primary Care Paediatricians, Lyon, France.,Association Française de Pédiatrie Ambulatoire, Talence, France
| | - Stefano Del Torso
- The European Academy of Paediatrics, Brussels, Belgium.,Childcare Worldwide, Padova, Italy
| | - Hans Jürgen Dornbusch
- The European Academy of Paediatrics, Brussels, Belgium.,Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria
| | - Artur Mazur
- The European Academy of Paediatrics, Brussels, Belgium.,Medical Faculty, University of Rzeszow, Rzeszów, Poland
| | - Katarzyna Albrecht
- Department of Pediatric, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland
| | - Adamos Hadjipanayis
- The European Academy of Paediatrics, Brussels, Belgium.,School of Medicine, European University Cyprus, Nicosia, Cyprus.,Paediatric Department, Larnaca General Hospital, Larnaca, Cyprus
| |
Collapse
|